PubRank

Colleen Olive

Author PubWeight™ 16.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 M protein typing of Thai group A streptococcal isolates by PCR-Restriction fragment length polymorphism analysis. BMC Microbiol 2005 1.10
2 Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo. Adv Mater 2012 1.01
3 Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines 2010 0.96
4 Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein. J Autoimmun 2003 0.94
5 B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis. Infect Immun 2009 0.94
6 Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases. Mol Immunol 2010 0.88
7 Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease. Immunol Res 2006 0.84
8 Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells. J Infect Dis 2010 0.83
9 Oral vaccine delivery--new strategies and technologies. Curr Drug Deliv 2009 0.82
10 Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines. Vaccine 2009 0.81
11 Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation. J Med Chem 2006 0.80
12 Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes. J Med Chem 2002 0.79
13 Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines. J Med Chem 2008 0.79
14 Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage. J Med Chem 2004 0.79
15 Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines. J Med Chem 2007 0.79
16 Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes. Vaccine 2006 0.78
17 Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation. J Org Chem 2006 0.78
18 Toll-like receptor-mediated adjuvanticity and immunomodulation in dendritic cells: Implications for peptide vaccines. Hum Vaccin 2011 0.78
19 Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population. BMC Microbiol 2006 0.78
20 Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model. Clin Vaccine Immunol 2011 0.76
21 Parenteral and mucosal delivery of a novel multi-epitope M protein-based group A streptococcal vaccine construct: investigation of immunogenicity in mice. Vaccine 2002 0.75
22 Method for the synthesis of highly pure vaccines using the lipid core peptide system. J Pept Sci 2006 0.75
23 Vaccine delivery utilizing liposaccharides. Adv Exp Med Biol 2009 0.75
24 Lipid and carbohydrate based adjuvant/carriers in immunology. J Pept Sci 2003 0.75
25 Vaccine delivery: synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate. Adv Exp Med Biol 2009 0.75